Former Microsoft life sciences commercial leader brings extensive experience advancing digital transformation across healthcare and technology
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Verily, an Alphabet precision health technology company, today announced the appointment of Bharat Rajagopal as Chief Revenue Officer. Rajagopal will join Verily’s leadership team and be responsible for the strategy and execution of all commercial revenue generating activities, including driving sales, business development, partnerships, and customer success to advance precision health.
Rajagopal brings more than two decades of experience leading commercial growth and digital transformation at Microsoft. While at Microsoft, Rajagopal held a series of customer-facing leadership roles, most recently, serving as the General Manager of Microsoft’s U.S. Life Sciences and MedTech business. In this role, he led a team of sales, technical, and operational leaders and partnered with pharma, medtech, and life science organizations to advance their digital transformation efforts to bring life-saving therapies to market faster. Rajagopal also partnered with next generation healthcare startups to build and scale on the Microsoft cloud.
“Bharat is a distinguished commercial executive with extensive experience driving technology adoption for some of the most innovative organizations across healthcare,” said Stephen Gillett, Chief Executive Officer at Verily. “His leadership and expertise will be critical as we deepen and scale our customer relationships to deliver on the promise of precision health.”
Prior to his role as General Manager, Rajagopal served as Chief Operating Officer of Microsoft’s Gulf Coast Enterprise & Partner Group. In this role, he drove significant enterprise software growth by enabling digital transformation for global customers in high tech, oil, and gas. In addition to his commercial leadership at Microsoft, Rajagopal frequently collaborates with external groups that set industry standards and remove barriers to the adoption of technology across life sciences.
“Over the last 20 years, my work has been focused on partnering with enterprises, including life sciences and medtech companies, to drive the adoption and use of transformative technologies,” said Bharat Rajagopal. “With the recent advances in AI, we have a generational opportunity to discover therapies never imagined before. I’m thrilled to continue my mission at Verily by partnering with organizations across the ecosystem to deliver new data, AI, and technology solutions that accelerate evidence generation and advance precision health.”
About Verily
Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information, please visit: verily.com
Contacts
Steven Cooper
Head of Media Relations, Verily
[email protected]
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.
